Crinetics Pharmaceuticals, Inc.San Diego, United States
Disclosure information not submitted.
SUN-023 - Long-Term Safety and Efficacy of Once-Daily Oral Paltusotine in Combination with Cabergoline for the Treatment of Patients with Acromegaly
Sunday, June 14, 202612:00 PM - 1:30 PM CT
Sunday, June 14, 20269:00 AM - 4:00 PM CT
